The convergence of Markov chain-based Monte Carlo linear solvers using the Ulamvon Neumann algorithm for a linear system of the form x = Hx + b is investigated in this paper. We analyze the convergence of the Monte Carlo solver based on the original Ulam-von Neumann algorithm under the conditions that H < 1 as well as ρ(H) < 1, where ρ(H) is the spectral radius of H. We find that although the Monte Carlo solver is based on sampling the Neumann series, the convergence of Neumann series is not a sufficient condition for the convergence of the Monte Carlo solver. Actually, properties of H are not the only factors determining the convergence of the Monte Carlo solver; the underlying transition probability matrix plays an important role. An improper selection of the transition matrix may result in divergence even though the condition H < 1 holds. However, if the condition H < 1 is satisfied, we show that there always exist certain transition matrices that guarantee convergence of the Monte Carlo solver. On the other hand, if ρ(H) < 1 but H ≥ 1, the Monte Carlo linear solver may or may not converge. In particular, if the row sum N j=1 |H ij | > 1 for every row in H or, more generally, ρ(H +) > 1, where H + is the nonnegative matrix where H + ij = |H ij |, we show that transition matrices leading to convergence of the Monte Carlo solver do not exist. Finally, given H and a transition matrix P , denoting the matrix H * via H * ij = H 2 ij /P ij , we find that ρ(H *) < 1 is a necessary and sufficient condition for convergence of the Markov chain-based Monte Carlo linear solvers using the Ulam-von Neumann algorithm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.